Hyloris Pharmaceuticals SaEURONEXT: HYL

Hyloris Pharmaceuticals Announces Positive Clinical Study Results for IV Aspirin

· Issued by Hyloris Pharmaceuticals SA

14 Nov 2025 07:38 CET

Subscribe
Issuer

HYLORIS PHARMACEUTICALS SA

pr-aspirin-iv-positive-clinical-trial-results.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext